Her findings can help to improve our understanding of the development of breast cancer in both dogs and humans.

Picture: Dog with a mammary tumor (Photo: Veronica Kristiansen)

Cancer is the most common cause of death in dogs and is therefore an important factor in the health of dogs. The incidence of cancer varies according to the breed of dog and this would indicate that genetic risk factors play an important role in the development of the disease. But we still know little about which genes and mutations can lead to the development of mammary tumours in dogs.

The oestrogen receptor gene is associated with the risk of mammary tumours
Borge studied known risk genes in dogs to learn more about the genes that predispose to canine mammary tumours. These genes are already known to be linked to cancer in humans. Borge discovered that there was a large variation in these genes from breed to breed. Some of the variants proved to have a detrimental effect and could lead to a potential change in the risk of developing cancer.

Borge compared the incidence of these genes in different groups of English springer spaniels with and without mammary tumours. The genes were also studied in another group of dogs from breeds having either a high or low incidence of mammary tumours. The results of these analyses indicate that variants of the oestrogen receptor gene are associated with the risk of English springer spanieldeveloping mammary tumours in dogs.

High frequency of genetic changes in tumours
Cancer occurs when mutations occurring over a period of time in several important genes change the function of these genes. Borge examined canine mammary tumours in order to identify mutations which have arisen in tumours and may therefore be involved in the development of cancer. She focused on changes in the number of gene copies where there was either a decrease or increase in gene areas in the tumours.

Borge found a large number of mutations and the number of aberrations increased, the more malignant the tumours turned out to be. She detected major cancer genes known to occur in humans but also identified new areas. Borge also demonstrated that linking detailed histopathological parameters from mammary tumour diagnostics to genetic mutations could help to chart specific genes that lead to the growth of tumours and to more malignant types of cancer.

Research on dogs can improve our knowledge about cancer
Increased knowledge about the genetic changes which cause cancer is essential for the prevention, diagnosis and treatment of the disease. The results of Borge's doctoral research will in the first instance help to improve our knowledge on the subject related to dogs, but they also show that there are many similarities between carcinogenic gene mutations in both canine and human breast cancer.

This means that studying dogs is a good way of identifying genetic risk factors for cancer and can also lead to a better understanding of how cancer develops in humans.

Borge carried out her study in conjunction with the Research Group for Medical Genetics at the Norwegian School of Veterinary Science.

Supervisors
Professor Frode Lingaas (main supervisor), the Norwegian School of Veterinary Science and professor Anne-Lise Børresen-Dale (co-supervisor), the Norwegian Radium Hospital/Oslo University Hospital

Kaja BorgeCand.med.vet. Kaja Sverdrup Borge defended her doctoral research on 29th November 2013 at the Norwegian School of Veterinary Science with a thesis entitled  ”Genetic characterization of canine mammary tumours: germline mutations and genomic aberrations”.

Biography
Kaja Sverdrup Bore (born 1982) comes from Oslo. She qualified as a veterinary surgeon at the Norwegian School of Veterinary Science in December 2007. Since 2008, she has been a research fellow in the Genetics Section of the Department of Basic Sciences and Aquatic Medicine at the Norwegian School of Veterinary Science.

Contact information
Kaja Sverdrup Borge
Tel. work: +47 22 96 45 37
Mobile: 951 46 336
Email: KajaSverdrup.Borge@nvh.no

Magnhild Jenssen, Information Officer at NVH
Tel.: +47 77 66 54 01
Mobile: +47 957 94 830
Email: magnhild.jenssen@nvh.no